Valeant increases offer for Allergan
Monday, November 3 2014 | 00 h 00 min | News
Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion In a letter to Allergan, Valeant...
Read MoreTough quarter for Johnson & Johnson in the eye care market
Monday, November 3 2014 | 00 h 00 min | News
Despite a good quarter for the company in general (sales of US$185 billion, up by 51% over last year), Johnson & Johnson reported a drop in eye...
Read MoreExcellent third quarter for Valeant
Monday, November 3 2014 | 00 h 00 min | News
Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in...
Read MoreEyeCheck shortlisted for prestigious James Dyson award
Wednesday, October 29 2014 | 00 h 00 min | News
EyeCheck, a start-up founded by University of Waterloo students, made the final list of 20 entries for the James Dyson Award The James Dyson Award...
Read MoreNew sports vision clinic at the University of Waterloo
Thursday, October 23 2014 | 00 h 00 min | News
The School of Optometry & Vision Science now has a clinic to promote sports vision research Directed by Professor Kristine Dalton, the Sports...
Read More
